Clinical characteristics of 45 patients with invasive pulmonary aspergillosis: Retrospective analysis of 1711 lung cancer cases

Cancer

Volumn 115, Issue 21, 2009, Pages 5018-5025

  Yan, Xi ^a   Li, Mei ^a   Jiang, Ming ^a   Zou, Li Qun ^a   Luo, Feng ^a   Jiang, Yu ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Clinical stage; Corticosteroid; Invasive pulmonary aspergillosis; Lung cancer; Neutropenia

Indexed keywords

ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; CORTICOSTEROID; FLUCONAZOLE; PREDNISONE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL EVALUATION; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; INFECTION RISK; LUNG ASPERGILLOSIS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPENIA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT DURATION; TREATMENT OUTCOME;

FEMALE; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEASONS;

EID: 70350501253     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24559     Document Type: Article

References (42)

1. Cornet M, Fleury L, Maslo C, Bernard JF, Brucker G; Invasive Aspergillosis Surveillance Network of the Assistance Publique-Hopitaux de Paris. Epidemiology of invasive aspergillosis in France: a 6-year multicentric survey in the Greater Paris area. J Hosp Infect. 2002;51:288-296.
2. Herbrecht R, Moghaddam A, Mahmal L, Natarajan-Ame S, Fornecker LM, Letscher-Bru V. Invasive aspergillosis in the hematologic and immunologic patient: new findings and key questions in leukemia. Med Mycol. 2005;43(suppl 1):S239-S242. (Pubitemid 41038573)
3. Kiertiburanakul S, Thibbadee C, Santanirand P. Invasive aspergillosis in a tertiary-care hospital in Thailand. J Med Assoc Thai. 2007;90:895-902. (Pubitemid 46790352)
4. Soubani AO, Chandrasekar PH. The clinical spectrum of pulmonary aspergillosis. Chest. 2002;121:1988-1999.
5. Shahid M, Malik A, Bhargava R. Prevalence of aspergillosis in chronic lung diseases. Indian J Med Microbiol. 2001;19: 201-205.
6. Denning DW. Invasive aspergillosis. Clin Infect Dis. 1998; 26:781-803.
7. Park CK, Jheon S. Results of surgical treatment for pulmonary aspergilloma. Eur J Cardiothorac Surg. 2002;21:918-923. (Pubitemid 34308954)
8. Shahid M, Malik A, Bhargava R. Bronchogenic carcinoma and secondary aspergillosis-common yet unexplored: evaluation of the role of bronchoalveolar lavage-polymerase chain reaction and some nonvalidated serologic methods to establish early diagnosis. Cancer. 2008;113:547-558.
9. Malik A, Shahid M, Bhargava R. Prevalence of aspergillosis in bronchogenic carcinoma. Indian J Pathol Microbiol. 2003;46:507-510.
10. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813-1821.
11. Burgos A, Zaoutis TE, Dvorak CC, et al. Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases. Pediatrics. 2008;121:e1286-e1294.
12. Ninin E, Milpied N, Moreau P, et al. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. Clin Infect Dis. 2001;33: 41-47. (Pubitemid 32554501)
13. Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood. 2002;100: 4358-4366. (Pubitemid 35429674)
14. Grow WB, Moreb JS, Roque D, et al. Late onset of invasive Aspergillus infection in bone marrow transplant patients at a university hospital. Bone Marrow Transplant. 2002;29: 15-19. (Pubitemid 34126493)
15. Subira M, Martino R, Franquet T, et al. Invasive pulmonary aspergillosis in patients with hematologic malignancies: survival and prognostic factors. Haematologica. 2002;87: 528-534. (Pubitemid 34533280)
16. Ohmagari N, Raad II, Hachem R, Kontoyiannis DP. Invasive aspergillosis in patients with solid tumors. Cancer. 2004;101:2300-2302. (Pubitemid 39458687)
17. Groll AH, Shah PM, Mentzel C, Schneider M, Just- Nuebling G, Huebner K. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect. 1996;33:23-32. (Pubitemid 26289847)
18. Caras I, Grigorescu A, Stavaru C, et al. Evidence for immune defects in breast and lung cancer patients. Cancer Immunol Immunother. 2004;53:1146-1152. (Pubitemid 39506403)
19. Gao Y, Tang W, Dai X, et al. Effects of water-soluble Ganoderma lucidum polysaccharides on the immune functions of patients with advanced lung cancer. J Med Food. 2005;8:159-168. (Pubitemid 41008978)
20. Patterson TF, Kirkpatrick WR, White M, et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Med (Baltimore). 2000;79:250-260.
21. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis. 2001;32:358-366. (Pubitemid 32173620)
22. Crassard N, Hadden H, Pondarre C, et al. Invasive aspergillosis and allogeneic hematopoietic stem cell transplantation in children: a 15-year experience. Transpl Infect Dis. 2008;10:177-183. (Pubitemid 351704012)
23. Soubani AO, Qureshi MA. Invasive pulmonary aspergillosis following bone marrow transplantation: risk factors and diagnostic aspect. Haematologia (Budap). 2002;32:427-437.
24. Nosari A, Oreste P, Cairoli R, et al. Invasive aspergillosis in haematological malignancies: clinical findings and management for intensive chemotherapy completion. Am J Hematol. 2001;68:231-236. (Pubitemid 33108425)
25. Reichenberger F, Habicht JM, Gratwohl A, Tamm M. Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients. Eur Respir J. 2002;19:743-755. (Pubitemid 34285172)
26. Jiang Y, Li JY, Li M, Zhou L, Peng F, Wei YQ. Clinical analysis of nosocomial pulmonary fungal infection in patients with cancer. Ai Zheng. 2004;23:1707-1709.
27. Batura-Gabryel H, Firlik M, Wieczorek U. Evaluation of occurrence of fungal infection in patients with lung cancer. Med Dosw Mikrobiol. 1994;46:79-81.
28. Panagopoulou P, Filioti J, Petrikkos G, et al. Environmental surveillance of filamentous fungi in 3 tertiary care hospitals in Greece. J Hosp Infect. 2002;52:185-191. (Pubitemid 38001926)
29. Wald A, Leisenring W, van Burik JA, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis. 1997;175:1459-1466. (Pubitemid 27225051)
30. Hospenthal DR, Kwon-Chung KJ, Bennett JE. Concentrations of airborne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlation. Med Mycol. 1998; 36:165-168. (Pubitemid 28332624)
31. Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis. 2007;44:531-540. (Pubitemid 46233255)
32. Guiot HF, Fibbe WE, van 't Wout JW. Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis. Clin Infect Dis. 1994;18:525-532.
33. Caillot D, Casasnovas O, Bernard A, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol. 1997;15:139-147. (Pubitemid 27020567)
34. Berenguer J, Allende MC, Lee JW, et al. Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone- induced immunosuppression. Am J Respir Crit Care Med. 1995;152:1079-1086.
35. Li D, Chen L, Ding X, Tao R, Zhang YX, Wang JF. Hospital- acquired invasive pulmonary aspergillosis in patients with hepatic failure [serial online]. BMC Gastroenterol. 2008;8:32.
36. Garbino J, Rohner P, Kolarova L, Ondrusova A, Lew D. Successful treatment of pulmonary invasive aspergillosis with voriconazole in patients who failed conventional therapy. Infection. 2003;31:241-243. (Pubitemid 36960559)
37. Rijnders BJ, Cornelissen JJ, Slobbe L, et al. Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial. Clin Infect Dis. 2008; 46:1401-1408. (Pubitemid 351589940)
38. Kobayashi R, Kaneda M, Sato T, Ichikawa M, Suzuki D, Ariga T. The clinical features of invasive fungal infection in pediatric patients with hematologic and malignant diseases: a 10-year analysis at a single institution at Japan. J Pediatr Hematol Oncol. 2008;30:886-890.
39. Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med. 2004;170:621-625. (Pubitemid 39202203)
40. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev. 1999;12:310-350.
41. Sanguinetti M, Posteraro B, Pagano L, et al. Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol. 2003;41:3922-3925. (Pubitemid 36994742)
42. Clancy CJ, Jaber RA, Leather HL, et al. Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients. J Clin Microbiol. 2007;45:1759-1765. (Pubitemid 46933903)